Literature DB >> 19548058

Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia.

Eric J Belin de Chantemèle1, M Irfan Ali, James Mintz, David W Stepp.   

Abstract

Impairment of vascular growth is a hallmark of diabetic complications, but the progression and mechanisms are poorly understood. To determine whether obesity and early diabetes impair endothelium-dependent vasodilatation and vascular response to ischemia, microvascular function as well as angiogenic responses to ischemia were assessed in young (C57) and 6-month-old lean mice (old C57), in obese (db-C57) mice, and in mice suffering an early (db-KsJ) and sustained type 2 diabetes (old db-KsJ). Glycemia gradually increased from the db-C57 to the old db-KsJ. Early and established type II diabetes significantly reduced the level of insulin that was significantly increased in obese mice. Endothelial function was assessed in isolated resistance arteries while the angiogenic response induced by unilateral hindlimb ischemia was analyzed, after 28 days, with a laser Doppler flowmeter and angiography. Aging (-21%), obesity (-45%), as well as early (-58%) and sustained type II diabetes (-69%) induced a progressive impairment of the endothelium-dependent relaxation of the gracilis artery. Laser Doppler measurements demonstrated that only early and sustained type II diabetes impaired skin blood flow recovery. Vascular collateralization was reduced with aging and severely impaired in older db-KsJ mice, the two strains of mice in which ischemia reduced eNOS expression. These results demonstrate that endothelial dysfunction induced by obesity is insufficient to alter the angiogenic response to ischemia. Furthermore, the development of frank type II diabetes or increasing age is required to impair the vascular response to hindlimb ischemia. We conclude that additional risk factors or severe endothelial dysfunction may be requisite to impede the angiogenic response to ischemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548058      PMCID: PMC3472443          DOI: 10.1007/s00395-009-0042-2

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  48 in total

Review 1.  Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view.

Authors:  Peter W F Wilson
Journal:  Endocrinol Metab Clin North Am       Date:  2004-09       Impact factor: 4.741

2.  The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains.

Authors:  K P Hummel; D L Coleman; P W Lane
Journal:  Biochem Genet       Date:  1972-08       Impact factor: 1.890

3.  Function of the pancreatic B-cell during the development of hyperglycaemia in mice homozygous for the mutations "diabetes" (db) and "misty" (m).

Authors:  R Gunnarsson
Journal:  Diabetologia       Date:  1975-10       Impact factor: 10.122

4.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

Authors:  M Ziche; L Morbidelli; R Choudhuri; H T Zhang; S Donnini; H J Granger; R Bicknell
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

5.  Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

Authors:  E Van Belle; A Rivard; D Chen; M Silver; S Bunting; N Ferrara; J F Symes; C Bauters; J M Isner
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

6.  Mouse model of angiogenesis.

Authors:  T Couffinhal; M Silver; L P Zheng; M Kearney; B Witzenbichler; J M Isner
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

7.  Development of the insulin secretory defect in genetically diabetic (db/db) mouse.

Authors:  O Berglund; B J Frankel; B Hellman
Journal:  Acta Endocrinol (Copenh)       Date:  1978-03

8.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.

Authors:  T Murohara; T Asahara; M Silver; C Bauters; H Masuda; C Kalka; M Kearney; D Chen; J F Symes; M C Fishman; P L Huang; J M Isner
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.

Authors:  Robert D Galiano; Oren M Tepper; Catherine R Pelo; Kirit A Bhatt; Matthew Callaghan; Nicholas Bastidas; Stuart Bunting; Hope G Steinmetz; Geoffrey C Gurtner
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Influence of the mutation "diabetes" on insulin release and islet morphology in mice of different genetic backgrounds.

Authors:  L Boquist; B Hellman; A Lernmark; I B Täljedal
Journal:  J Cell Biol       Date:  1974-07       Impact factor: 10.539

View more
  10 in total

Review 1.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

Review 2.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

Review 3.  Heart of the matter: coronary dysfunction in metabolic syndrome.

Authors:  Zachary C Berwick; Gregory M Dick; Johnathan D Tune
Journal:  J Mol Cell Cardiol       Date:  2011-07-13       Impact factor: 5.000

4.  Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.

Authors:  Paige S Katz; Aaron J Trask; Flavia M Souza-Smith; Kirk R Hutchinson; Maarten L Galantowicz; Kevin C Lord; James A Stewart; Mary J Cismowski; Kurt J Varner; Pamela A Lucchesi
Journal:  Basic Res Cardiol       Date:  2011-07-10       Impact factor: 17.165

5.  Interferon-gamma induced adipose tissue inflammation is linked to endothelial dysfunction in type 2 diabetic mice.

Authors:  Hanrui Zhang; Barry J Potter; Ji-Min Cao; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-08-09       Impact factor: 17.165

6.  Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice.

Authors:  Hanrui Zhang; Yong Wang; Jing Zhang; Barry J Potter; James R Sowers; Cuihua Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-16       Impact factor: 8.311

7.  Contribution of electromechanical coupling between Kv and Ca v1.2 channels to coronary dysfunction in obesity.

Authors:  Zachary C Berwick; Gregory M Dick; Heather A O'Leary; Shawn B Bender; Adam G Goodwill; Steven P Moberly; Meredith Kohr Owen; Steven J Miller; Alexander G Obukhov; Johnathan D Tune
Journal:  Basic Res Cardiol       Date:  2013-07-16       Impact factor: 17.165

8.  Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia.

Authors:  Antonio D Lassaletta; Louis M Chu; Michael P Robich; Nassrene Y Elmadhun; Jun Feng; Thomas A Burgess; Roger J Laham; Michael Sturek; Frank W Sellke
Journal:  Basic Res Cardiol       Date:  2012-01-10       Impact factor: 17.165

9.  Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.

Authors:  Ahmed A Elmarakby; John D Imig
Journal:  Clin Sci (Lond)       Date:  2010-02       Impact factor: 6.124

10.  Effects of some anesthetic agents on skin microcirculation evaluated by laser Doppler perfusion imaging in mice.

Authors:  Sara Gargiulo; Matteo Gramanzini; Raffaele Liuzzi; Adelaide Greco; Arturo Brunetti; Giancarlo Vesce
Journal:  BMC Vet Res       Date:  2013-12-17       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.